CAI Caris Life Sciences, Inc.
Caris Life Sciences, Inc. (CAI) is expected to report earnings on November 4, 2026, after the market close. The consensus earnings estimate is $0.03 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +14.7% since its last earnings release on August 5, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Caris Life Sciences, Inc.
Caris Life Sciences® (Caris) is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer that is actively developing and commercializing innovative solutions to transform healthcare.
Sector
Healthcare
Industry
Medical Labs & Research